Home Contact News

News

Find out more …

FAQs
News
Contact
Filter results
E.g., 21/10/2021
E.g., 21/10/2021
21/10/2021
The FDA delays its decision on Risperidone ISM®
Download
01/09/2021
ROVI informs about the joint statement from Moderna and Takeda on the investigation of suspended lots of the vaccine
Download
29/08/2021
ROVI informs on the evolution of the investigation of particulate matter having been seen in certain drug product vials of the Moderna COVID-19 vaccine distributed in Japan
Download
26/08/2021
ROVI informs on the notification of particulate matter having been seen in certain drug product vials of the Moderna's COVID-19 vaccine distributed in Japan
Download
09/08/2021
ROVI achieves second place in a worldwide sustainability rating
Download
28/07/2021
First half 2021 results presentation
Operating income, growth figures, profitability and how our products have behaved.
Download
28/07/2021
First Half 2021 Results Press Release
Download our press release published on 28 July to find out the financial results for the first half of 2021.
Download
17/06/2021
ROVI holds its 2021 General Shareholders' Meeting
ROVI increases operating income by 10% and net profit by 55% in 2020
Download
13/05/2021
First quarter 2021 results presentation
Operating income, growth figures, profitability and how our products have behaved.
Download

Pages